Disease | colorectal cancer |
Symptom | C0346989|peritoneal metastases |
Sentences | 11 |
PubMedID- 25071322 | Update on the prevention of local recurrence and peritoneal metastases in patients with colorectal cancer. |
PubMedID- 23793379 | Results: of the 564 colorectal cancer patients with synchronous peritoneal metastases, 341 also had hematogenous metastases. |
PubMedID- 26153356 | colorectal cancer with peritoneal metastases: progress, not perfection. |
PubMedID- 25135985 | Results: of the 564 colorectal cancer patients with synchronous peritoneal metastases, 341 had hematogenous metastases. |
PubMedID- 22034185 | Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases. |
PubMedID- 25954110 | Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab. |
PubMedID- 24794253 | Liver, lung and peritoneal metastases in colorectal cancers: is the patient still curable. |
PubMedID- 26178340 | colorectal cancer with peritoneal metastases: a plea for cooperation between medical and surgical oncologists. |
PubMedID- 26424828 | In the era of 5-fluorouracil (5-fu)-only chemotherapy, the prognosis was poor for colorectal cancer with peritoneal metastases. |
PubMedID- 26377391 | The aim of this study was to investigate the factors affecting recurrence and prognosis after r0 resection for colorectal cancer with synchronous peritoneal metastases. |
PubMedID- 24242680 | Background: cytoreductive surgery (crs) and hyperthermic intraperitoneal chemotherapy (hipec) has improved the survival in selected colorectal cancer patients with peritoneal metastases. |
Page: 1